The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer.

Autor: Şen GA; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey. gulinalkan@msn.com., Aydın E; Department of Medical Oncology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey., Guliyev M; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey., Öztaş NŞ; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey., Değerli E; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey., Demirci NS; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey., Turna ZH; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey., Demirelli FH; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Publikováno v: BMC cancer [BMC Cancer] 2024 Oct 24; Vol. 24 (1), pp. 1311. Date of Electronic Publication: 2024 Oct 24.

Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors.

Autor: Şen GA; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey. gulinalkan@msn.com., Öztaş NŞ; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Değerli E; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Guliyev M; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Can G; Department of Public Health, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Turna H; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Özgüroğlu M; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Sep 03. Date of Electronic Publication: 2024 Sep 03.

A New Tool to Determine the Accurate Lateral Osteotomy Line in Rhinoplasty with Piezosurgery.

Autor: Guliyev M; Department of Otolaryngology, Azerbaijan State Advanced Training Institute for Doctors named after Aziz Aliyev, Ministry of Health, Baku, Azerbaijan. dr.mezahirq@gmail.com.; Badam Klinikası, Bakı şeh. Abbasgulu Abbaszadeh 13a, Baku, Azerbaijan. dr.mezahirq@gmail.com.

Publikováno v: Aesthetic plastic surgery [Aesthetic Plast Surg] 2024 Jun 26. Date of Electronic Publication: 2024 Jun 26.

Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.

Autor: Yildirim HC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.; Department of Medical Oncology, Nigde Research and Education Hospital, Nigde, Turkey., Kapar C; Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Sanci PC; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Guliyev M; Department of Medical Oncology, Istanbul Cerrahpasa University Faculty of Medicine, Istanbul, Turkey., Perkin P; Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey., Buyukkor M; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey., Yaslikaya S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Majidova N; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Keskinkilic M; Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey., Ozaskin D; Department of Medical Oncology, Afyon Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Avci T; Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey., Gunes TK; Department of Medical Oncology, Umraniye Research and Education Hospital, Istanbul, Turkey., Arcagok M; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey., Topal A; Department of Medical Oncology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey., Keskin GSY; Department of Medical Oncology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey., Kavgaci G; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Celayir OM; Department of Medical Oncology, Acibadem University Faculty of Medicine, Istanbul, Turkey., Avci N; Department of Medical Oncology, Medicana Hospital, Bursa, Turkey., Aslan F; Department of Medical Oncology, Medical Park Ankara Hospital, Ankara, Turkey., Alkan A; Department of Medical Oncology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, Turkey., Erciyestepe M; Department of Medical Oncology, Istanbul Prof. Dr. Cemil Tascioglu State Hospital, Istanbul, Turkey., Cengiz M; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey., Pehlivan M; Department of Medical Oncology, Zonguldak Ataturk State Hospital, Zonguldak, Turkey., Gulmez A; Department of Medical Oncology, Adana City Education and Research Hospital, Adana, Turkey., Beypinar I; Department of Medical Oncology, Alaaddin Keykubat University Faculty of Medicine, Antalya, Turkey., Basoglu Tuylu T; Department of Medical Oncology, Nigde Research and Education Hospital, Nigde, Turkey., Kayikcioglu E; Department of Medical Oncology, Isparta Suleyman Demirel University Faculty of Medicine, Isparta, Turkey., Chalabiyev E; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Turhal S; Department of Medical Oncology, Anadolu Health Center, Istanbul, Turkey., Guzel HG; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ayas E; Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey., Sahbazlar M; Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey., Dulgar O; Department of Medical Oncology, Umraniye Research and Education Hospital, Istanbul, Turkey., Demir H; Department of Medical Oncology, Afyon Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Yavuzsen T; Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey., Bayoglu V; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Kivrak Salim D; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ozturk B; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ozdemir F; Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey., Kara O; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Oksuzoglu B; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey., Bal O; Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey., Demirci NS; Department of Medical Oncology, Istanbul Cerrahpasa University Faculty of Medicine, Istanbul, Turkey., Yilmaz M; Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey., Cabuk D; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Mar 18, pp. 1-7. Date of Electronic Publication: 2024 Mar 18.

PREVENTION OF COMPLICATIONS IN REMOVABLE LAMELLAR PROSTHETICS

Autor: İsmaylov D., Guliyev M., Zeynalova Zh.

The factors influencing the tissues of the oral cavity and the prosthetic bed, which contribute to the unsatisfactory functioning of removable lamellar dentures, as well as their premature failure, have been studied. Measures for the prevention of co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b24776c5f0e074adb3ac0b2b4d1a74c